gastroenterology
Cancer

NICE backs aspirin chemoprevention of CRC


People with Lynch syndrome should be offered aspirin to reduce their risk of colorectal cancer, the UK’s National Institute for Health and Care Excellence (NICE) is recommending. The draft NICE guidance, currently out for consultation, recommends that aspirin use for at least two years be considered in people with Lynch syndrome  – also known as ...

Already a member?

Enter your email to keep reading.


OR